IdentifAI Genetics Company

IdentifAI Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders. Using a simple first-trimester maternal blood test to access the entire embryonic genome, Identifai can perform a comprehensive analysis capable of detecting every single-point mutation, insertion-deletion, and structural variation in order to identify severe genetic disorders.

Headquarters: Tel Aviv, Tel Aviv, Israel
Last Funding Date: 2021-12-01
Total Funding: 2450000
Last Funding Type: Grant
Founded Date: 2020
Investors Number: 2
Industry: Pregnancy, Maternal Health & Nursing
Employee Number: 1-10
Funding Status: Seed